scispace - formally typeset
S

Sandra Guaita-Esteruelas

Researcher at Carlos III Health Institute

Publications -  19
Citations -  485

Sandra Guaita-Esteruelas is an academic researcher from Carlos III Health Institute. The author has contributed to research in topics: Adipose tissue & Fatty acid-binding protein. The author has an hindex of 11, co-authored 19 publications receiving 348 citations.

Papers
More filters
Journal ArticleDOI

Exogenous FABP4 increases breast cancer cell proliferation and activates the expression of fatty acid transport proteins

TL;DR: It is shown that eFABP4 plays a key role in tumor proliferation and activates the expression of fatty acid transport proteins in MCF‐7 breast cancer cells.
Journal ArticleDOI

The peritumoural adipose tissue microenvironment and cancer. The roles of fatty acid binding protein 4 and fatty acid binding protein 5.

TL;DR: The role of the peritumoural adipose tissue and the related adipokines FABp4 and FABP5 in cancer initiation and progression and the possible pathways implicated in these processes are discussed.
Journal ArticleDOI

Clinical and pathophysiological evidence supporting the safety of extremely low LDL levels—The zero-LDL hypothesis

TL;DR: It is suggested that extremely low LDL-C levels due to increased LDLR activity may be a surrogate of adequate LDL-LDLR pathway function, which is the main mechanism for removal of cholesterol from the body.
Journal ArticleDOI

FABP4 inhibitor BMS309403 decreases saturated-fatty-acid-induced endoplasmic reticulum stress-associated inflammation in skeletal muscle by reducing p38 MAPK activation.

TL;DR: Findings indicate that FABP4 inhibitor BMS309403 reduces fatty acid-induced ER stress-associated inflammation in skeletal muscle by reducing p38 MAPK activation.
Journal ArticleDOI

The Circulating GRP78/BiP Is a Marker of Metabolic Diseases and Atherosclerosis: Bringing Endoplasmic Reticulum Stress into the Clinical Scenario.

TL;DR: GRP78/BiP plasma concentrations are increased in patients with both metabolic derangements and subclinical atherosclerosis, suggesting that this protein could be a useful marker of metabolic and cardiovascular risk.